Modalina (Trifluoperazine Hydrochloride)

Trifluoperazine hydrochloride, the active ingredient in Modalina, is a phenothiazine antipsychotic presented as an oral tablet for oral use. It is employed to manage schizophrenia and other psychotic disorders in adult patients. GNH USA supplies Modalina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Trifluoperazine hydrochloride is a typical antipsychotic that acts on dopamine pathways to control psychotic conditions. - Schizophrenia: alleviates positive and negative symptoms and improves overall functioning. - Acute psychotic disorders: reduces agitation, hallucinations, and delusions during crisis episodes. - Chronic psychosis maintenance: helps prevent relapse and stabilizes long‑term mental health.

Trifluoperazine may cause a range of adverse reactions, ranging from mild to serious.

Common Side Effects: - Sedation: feeling unusually sleepy or drowsy. - Dry mouth: reduced salivation leading to discomfort. - Constipation: slowed gastrointestinal motility. - Blurred vision: temporary visual disturbances. - Weight gain: increase in body weight over time. - Orthostatic hypotension: dizziness upon standing.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: life‑threatening reaction with fever and muscle rigidity. - Tardive dyskinesia: involuntary movements of face and limbs. - Severe hypotension: marked drop in blood pressure. - Cardiac arrhythmia: irregular heart rhythm. - Agranulocytosis: dangerously low white blood cell count. - Seizures: risk of convulsive episodes.

When prescribing or dispensing trifluoperazine, several safety considerations are important. - Renal or hepatic impairment: monitor liver and kidney function closely. - Elderly patients: increased risk of falls and sedation; start at low dose. - History of cardiac disease: obtain baseline ECG and monitor for arrhythmias. - Concomitant CNS depressants: risk of excessive sedation or respiratory depression. - Pregnancy and lactation: safety not established; weigh benefits against risks. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Trifluoperazine can interact with other medicines, affecting its safety and efficacy.

Major Interactions (Avoid): - CYP1A2 inhibitors (e.g., fluvoxamine): may increase plasma concentrations. - CYP2D6 inhibitors (e.g., quinidine): can raise risk of toxicity. - Antihypertensive agents: additive hypotensive effect.

Moderate Interactions (Monitor Closely): - Other antipsychotics: may enhance central nervous system depression. - Anticholinergic drugs: increased anticholinergic burden. - Lithium: monitor serum levels for potential neurotoxicity.